+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens



Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens



Diagnostic Microbiology and Infectious Disease 71(3): 279-285



Cerebral toxoplasmosis is the most common neurologic opportunistic infection in HIV-infected patients. Excretory-secretory antigens (ESA) are the majority of the circulating antigens in sera from hosts with acute toxoplasmosis, and their usefulness as antigens has been shown. This study considered whether it could find anti-ESA antibodies in cerebrospinal fluid (CSF) and whether these antibodies can be markers of active infection. Samples of CSF from 270 HIV-infected patients were analyzed and divided into 3 groups according to the presence or absence of active toxoplasmosis. Group I: 99 patients with cerebral toxoplasmosis; group II: 112 patients with other opportunistic neurologic diseases and seropositive for toxoplasmosis; and group III: 59 patients with other opportunistic neurologic diseases and seronegative for toxoplasmosis. Toxoplasma gondii ESA and a crude tachyzoite antigen were used as antigens using ELISA and immunoblotting. The statistical analysis was done using the F test and unpaired Student's t test. Crude tachyzoite antigen: mean ELISA-relative values ± standard error for CSF of groups I and II were 7.0 ± 0.27 and 3.9 ± 0.19, respectively. Variance analysis revealed that results of both groups of patients were statistically different (1.80, P = 0.0025). The difference between the mean results was 3.0 ± 0.3, and the Student's t test value was 9.41 (P = 0.0001). Samples from groups I and II were reactive by immunoblotting, with similar intensities. In ESA-ELISA, the mean for group I was 9.0 ± 0.39. Group II showed a mean value of 2.7 ± 0.12. Both groups were statistically different (9.16, P < 0.001). However, in ESA, the difference between the mean results was higher (6.2 ± 0.39) and the Student's t test value was 16.04 (P < 0.0001). Similar results were shown in immunoblotting where a CSF sample from group I reacted well with ESA, and the sample from a group II patient failed to do so. The mean ELISA-relative value of the control group (group III) was 0.5 ± 0.09 for the first antigen and 0.4 ± 0.22 for the second. ESA-ELISA and/or immunoblotting of CSF samples can be used for diagnosis of cerebral toxoplasmosis in association with clinical, serologic, and radiological information, thus providing a simple straightforward methodology, particularly suitable in countries with high prevalence of latent toxoplasmosis in the general population.

(PDF emailed within 0-6 h: $19.90)

Accession: 053700288

Download citation: RISBibTeXText

PMID: 21907524

DOI: 10.1016/j.diagmicrobio.2011.07.008


Related references

Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. Journal of Medical Microbiology 57(Pt 7): 845-850, 2008

Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients usingToxoplasma gondiiexcreted/secreted antigens. 2011

IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients. Journal of Immunological Methods 395(1-2): 21-28, 2013

Immune responses induced by intranasal immunization with Toxoplasma gondii excreted/secreted antigens extracted from peritoneal fluid of infected mice. 2007

Evaluation of the second fraction of excreted/secreted antigens from Toxoplasma gondii by ion exchange chromatography for serodiagnosis of toxoplasmosis in rat. Journal Of Mazandaran University Of Medical Sciences: 65, 628, 2008

Avidity of IgG antibodies against excreted/secreted antigens of Toxoplasma gondii: immunological marker for acute recent toxoplasmosis. Revista Da Sociedade Brasileira de Medicina Tropical 41(2): 142-147, 2008

Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunology 10(5): 553-567, 1988

Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection. Clinical and Experimental Immunology 73(3): 376-382, 1988

Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. Journal of Infectious Diseases 165(5): 982-983, 1992

Kinetics study and characterisation of target excreted/secreted antigens of immunoglobulin G, M, A and E antibodies from mice infected with different strains of Toxoplasma gondii. Parasitology Research 80(1): 58-63, 1994

Diagnosis of cerebral toxoplasmosis by detection of Toxoplasma gondii tachyzoites in cerebrospinal fluid. Journal of Neurology 255(6): 939-941, 2008

Evaluation of excreted/secreted antigens derived from peritoneal of toxoplasma infected small mice to detect IgG against Toxoplasma. Pakistan Journal of Biological Sciences 12(6): 530-533, 2009

Antibody responses to Toxoplasma gondii antigens in aqueous and cerebrospinal fluids of cats infected with Toxoplasma gondii and FIV. Comparative Immunology Microbiology & Infectious Diseases 15(4): 293-299, 1992

Nonimmunological factors affecting the release of excreted/secreted antigens from Toxoplasma gondii cysts. Zentralblatt für Bakteriologie 284(2-3): 378-389, 1996

Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway. Journal of Cellular Biochemistry 119(12): 10176-10185, 2018